Kids aged 3 to 17 years old in UAE may now receive Sinopharm vaccine
The Ministry of Health and Prevention (MOHAP) in the UAE has announced the provision of Sinopharm Covid-19 vaccine for the age group of three to 17.
MoHAP announced the provision of Sinopharm vaccine for the age group 3 – 17 The decision comes after clinical trials and extensive evaluations and is based on the emergency use authorization and local evaluations which are in line with the approved regulations.#TogetherWeRecover pic.twitter.com/4Y3VEMMW8V— NCEMA UAE (@NCEMAUAE) August 2, 2021
According to a Twitter post made by the National Emergency Crisis and Disasters Management Authority (NCEMA), the decision comes after clinical trials and extensive evaluations and is based on the emergency use authorization and local evaluations which are in line with the approved regulations.
“The enrollment registration for this study has been successful as we have attracted the desired number of children within a short period of time. I would like to thank everyone who took the initiative to register and participate in this study to support the country’s efforts to combat the COVID-19 pandemic. This reflects the public’s confidence and trust in the UAE’s long-term recovery plan and in the competence of the healthcare sector of the country,” Dr. Nawal Kaabim, Principal Investigator for Phase III Trials Covid-19 vaccine and Chief Medical Officer at Sheikh Khalifa Medical City told The Filipino Times.